VELOCITY: An Anthrax Vaccine Clinical Study
ClinicalTrials.gov NCT03877926
Research payments
$26,936,225
Through program year 2020, $26,936,225 in research payments was reported against VELOCITY: An Anthrax Vaccine Clinical Study, across 31,919 payments, paid by Emergent BioSolutions Inc..
- Paid by
- Emergent BioSolutions Inc.
- ClinicalTrials.gov
- NCT03877926
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $2,925,134 | 8,311 |
| 2019 | Research | $24,011,091 | 23,608 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Cynthia Strout Mt Pleasant, SC Named on 1,976 payments
- Barbara Rizzardi Sandy, UT Named on 1,871 payments
- Kathleen Jones West Des Moines, IA Named on 1,747 payments
- George Bauer Metairie, LA Named on 1,726 payments
- Mark Turner Meridian, ID Named on 1,694 payments
- Earl Martin Tomball, TX Named on 1,484 payments
- Brandon Essink Creighton, NE Named on 1,399 payments
- Paul Pickrell Austin, TX Named on 1,326 payments
- Andrew Bartlett Champaign, IL Named on 1,304 payments
- Donald Brandon San Diego, CA Named on 1,228 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.